Oncode Oncology Bridge Fund
Description
The Oncode Oncology Bridge Fund provides early stage financing to help the creation and growth of new enterprises
Investor Profile
Oncode Oncology Bridge Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A rounds (top funding stages).
- Majority of deals are located in The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series A (100%)
Country Focus
- The Netherlands (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
